Advertisement

Bupivacaine Injection

[02 July 2015]

Products Affected - Description

Bupivacaine injection, Hospira
0.25%, 20 mL glass ampule, sterile pack, 5 count (NDC 00409-4272-01)
0.25%, 30 mL glass ampule, 25 count (NDC 00409-1158-01)
0.5%, 20 mL glass ampule, sterile pack, 5 count (NDC 00409-4273-01)

Sensorcaine-MPF, Fresenius Kabi
0.25%, 10 mL vial, preservative-free, 25 count (NDC 63323-0464-17
0.25%, 30 mL vial, preservative-free, sterile pack, 25 count (NDC 63323-0464-31)
0.5%, 10 mL vial, preservative-free, 25 count (NDC 63323- 0466-17)

0.75%, 10 mL vial, preservative-free, 25 count (NDC 63323-0472-17

Reason for the Shortage

  • Fresenius Kabi has Sensorcaine on shortage due to increased demand for the product.
  • Hospira has bupivacaine on shortage due to manufacturing delays.
  • AuroMedics introduced bupivacaine injection in February 2014.

Available Products

Bupivacaine injection, AuroMedics
0.25%, 10 mL vial, preservative-free, 25 count (NDC 55150-0167-10)
0.25%, 30 mL vial, preservative-free, 25 count (NDC 55150-0168-30)
0.5%, 10 mL vial, preservative-free, 25 count (NDC 55150-0169-10)
0.5%, 30 mL vial, preservative-free, 25 count (NDC 55150-0170-30)
0.75%, 10 mL vial, preservative-free, 25 count (NDC 55150-0171-10)
0.75%, 30 mL vial, preservative-free, 25 count (NDC 55150-0172-30)

Sensorcaine, Fresenius Kabi
0.25%, 50 mL vial, multi-dose, 25 count (NDC 63323-0465-57)
0.5%, 50 mL vial, multi-dose, 25 count (NDC 63323-0467-57)

Sensorcaine-MPF, Fresenius Kabi
0.25%, 30 mL vial, preservative-free, 25 count (NDC 63323-0464-37)
0.5%, 30 mL vial, preservative-free, 25 count (NDC 63323- 0466-37)
0.5%, 30 mL vial, preservative-free, sterile pack, 25 count (NDC 63323-0466-31)
0.75%, 30 mL vial, preservative-free, 25 count (NDC 63323-0472-37)
 
Bupivacaine injection, Hospira
0.25%, 10 mL vial, preservative-free, 25 count (NDC 00409-1159-01)
0.25%, 30 mL vial, preservative-free, 25 count (NDC 00409-1159-02)
0.25%, 50 mL vial, multi-dose, 25 count (NDC 00409-1160-01)
0.5%, 10 mL vial, preservative-free, 25 count (NDC 00409-1162-01)
0.5%, 30 mL vial, preservative-free, 25 count (NDC 00409-1162-02)
0.5%, 30 mL glass ampule, 25 count (NDC 00409-1161-01)
0.5%, 50 mL vial, multi-dose, 25 count (NDC 00409- 1163-01)
0.75%, 10 mL vial, preservative-free, 25 count (NDC 00409-1165-01)
0.75%, 30 mL vial, preservative-free, 25 count (NDC 00409-1165-02)

Marcaine injection, Hospira
0.25%, 10 mL vial, preservative-free, 10 count (NDC 00409-1559-10)
0.25%, 30 mL vial, preservative-free, 10 count (NDC 00409-1559-30)
0.25%, 50 mL vial, multi-dose, single count (NDC 00409-1587-50)
0.5%, 10 mL vial, preservative-free, 10 count (NDC 00409-1560-10)
0.5%, 30 mL vial, preservative-free, 10 count (NDC 00409-1560-29)
0.5%, 50 mL vial, multi-dose, single count (NDC 00409-1610-50)
0.75%, 10 mL vial, preservative-free, 10 count (NDC 00409-1582-10)
0.75%, 30 mL vial, preservative-free, 10 count (NDC 00409-1582-29)

Estimated Resupply Dates

  • Hospira has 0.25% bupivacaine 30 mL ampules and 20 mL ampule sterile packs and 0.5% bupivacaine 20 mL ampule sterile packs on back order and the company cannot estimate a release date.
  • Fresenius Kabi has 0.25% Sensorcaine-MPF 10 mL vials, 0.5% Sensorcaine-MPF 10 mL vials, and 0.75% Sensorcaine-MPF 10 mL vials on back order and the company estimates a release date of early-July 2015. The 0.25% Sensorcaine-MPF 30 mL vials in sterile pack are available with short expiration dating (< 9 months).

Related Shortages

Updated

July 2, June 1, April 9, 16, and 29, March 23, February 3, 24, and 26, 2015; December 2, 16, and 19, November 6 and 21, October 14 and 24, September 3 and 19, August 8, July 3 and 16, June 2, 19, and 26, May 21, April 7 and 25, March 17, February 7, 21, and 27, January 6, 2014; December 3, November 7 and 11, October 9 and 30, September 5, August 6, July 12, June 13, May 10, 17, and 24, April 4, March 5 and 13, February 7 and 17, January 17, 2013; December 12, November 9, October 22, September 19, August 9 and 22, July 10, June 18, May 17, April 16, March 7 and 27, 2012; February 8 and 22, January 5 and 25, 2012; December 7 and 21, November 16 and 21, 2011; University of Utah, Drug Information Service. Copyright 2015, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins

Advocacy Activity
Get the latest updates on ASHP's advocacy activity on drug shortages.
Advertisement